Inga Zilberstein Md New York City, NY - 10021

Inga Zilberstein Md is categorized under Gynecologists and OB GYNs in New York City, NY and active since 1990.

Inga Zilberstein Md was established in 1990, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Gynecologists and OB GYNs business, which does work in the B2C market, and is classified as a Gynecologists and OB GYNs, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Inga Zilberstein at the company’s single location by writing to 1317 3rd Avenue Floor 4, New York City, New York NY 10021 or by phoning (212) 734-0187. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Inga Zilberstein Md
Contact Person: Inga Zilberstein
Address: 1317 3rd Avenue Floor 4, New York City, New York 10021
Phone Number: (212) 734-0187
Website Address: travelclinicsnyc.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1990
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Gynecologists and OB GYNs
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Inga Zilberstein Md was started in 1990 to provide professional Gynecologists and OB GYNs under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Inga Zilberstein for inquiries that concern Inga Zilberstein Md by calling the company number (212) 734-0187, as your correspondence is most welcome. Additionally, the physical location of the single location of Inga Zilberstein Md can be found at the coordinates 40.771899,-73.958827 as well as the street address 1317 3rd Avenue Floor 4 in New York City, New York 10021.

For its online presence, you may visit Inga Zilberstein Md’s website at travelclinicsnyc.com and engage with its social media outlets through on Twitter and on Facebook.